Market open
AngioDynamics/$ANGO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AngioDynamics
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Ticker
$ANGO
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
748
Website
AngioDynamics Metrics
BasicAdvanced
$382M
-
-$5.55
0.59
-
Price and volume
Market cap
$382M
Beta
0.59
52-week high
$13.50
52-week low
$5.26
Average daily volume
479K
Financial strength
Current ratio
1.979
Quick ratio
1.098
Long term debt to equity
1.622
Total debt to equity
2.628
Management effectiveness
Return on assets (TTM)
-5.71%
Return on equity (TTM)
-76.44%
Valuation
Price to revenue (TTM)
1.336
Price to book
2.06
Price to tangible book (TTM)
3.39
Price to free cash flow (TTM)
-12.928
Growth
Revenue change (TTM)
-13.06%
Earnings per share change (TTM)
1,463.55%
3-year revenue growth (CAGR)
-1.88%
3-year earnings per share growth (CAGR)
77.52%
What the Analysts think about AngioDynamics
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for AngioDynamics stock.
AngioDynamics Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
AngioDynamics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
AngioDynamics News
AllArticlesVideos
AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event
Business Wire·4 hours ago
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
Business Wire·1 week ago
AngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The Shares
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for AngioDynamics stock?
AngioDynamics (ANGO) has a market cap of $382M as of March 19, 2025.
What is the P/E ratio for AngioDynamics stock?
The price to earnings (P/E) ratio for AngioDynamics (ANGO) stock is 0 as of March 19, 2025.
Does AngioDynamics stock pay dividends?
No, AngioDynamics (ANGO) stock does not pay dividends to its shareholders as of March 19, 2025.
When is the next AngioDynamics dividend payment date?
AngioDynamics (ANGO) stock does not pay dividends to its shareholders.
What is the beta indicator for AngioDynamics?
AngioDynamics (ANGO) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.